141 related articles for article (PubMed ID: 9636285)
1. Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria.
Biocca S; Ruberti F; Tafani M; Pierandrei-Amaldi P; Cattaneo A
Biotechnology (N Y); 1995 Oct; 13(10):1110-5. PubMed ID: 9636285
[TBL] [Abstract][Full Text] [Related]
2. Targeting vectors for intracellular immunisation.
Persic L; Righi M; Roberts A; Hoogenboom HR; Cattaneo A; Bradbury A
Gene; 1997 Mar; 187(1):1-8. PubMed ID: 9073060
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco.
Schouten A; Roosien J; van Engelen FA; de Jong GA; Borst-Vrenssen AW; Zilverentant JF; Bosch D; Stiekema WJ; Gommers FJ; Schots A; Bakker J
Plant Mol Biol; 1996 Feb; 30(4):781-93. PubMed ID: 8624409
[TBL] [Abstract][Full Text] [Related]
4. Formation of disulfide bridges by a single-chain Fv antibody in the reducing ectopic environment of the plant cytosol.
Schouten A; Roosien J; Bakker J; Schots A
J Biol Chem; 2002 May; 277(22):19339-45. PubMed ID: 11916972
[TBL] [Abstract][Full Text] [Related]
5. The mode of action of Y13-259 scFv fragment intracellularly expressed in mammalian cells.
Cardinale A; Lener M; Messina S; Cattaneo A; Biocca S
FEBS Lett; 1998 Nov; 439(3):197-202. PubMed ID: 9845322
[TBL] [Abstract][Full Text] [Related]
6. Intracellular immunization with cytosolic recombinant antibodies.
Biocca S; Pierandrei-Amaldi P; Campioni N; Cattaneo A
Biotechnology (N Y); 1994 Apr; 12(4):396-9. PubMed ID: 7764686
[TBL] [Abstract][Full Text] [Related]
7. Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: a novel approach for cancer therapy?
Cochet O; Gruel N; Fridman WH; Teillaud JL
Cancer Detect Prev; 1999; 23(6):506-10. PubMed ID: 10571661
[TBL] [Abstract][Full Text] [Related]
8. Characterization of scFv-421, a single-chain antibody targeted to p53.
Jannot CB; Hynes NE
Biochem Biophys Res Commun; 1997 Jan; 230(2):242-6. PubMed ID: 9016757
[TBL] [Abstract][Full Text] [Related]
9. Intracellular expression and functional properties of an anti-p21Ras scFv derived from a rat hybridoma containing specific lambda and irrelevant kappa light chains.
Cochet O; Kenigsberg M; Delumeau I; Duchesne M; Schweighoffer F; Tocqué B; Teillaud JL
Mol Immunol; 1998 Dec; 35(17):1097-110. PubMed ID: 10395199
[TBL] [Abstract][Full Text] [Related]
10. Cells transfected with a non-neutralizing antibody gene are resistant to HIV infection: targeting the endoplasmic reticulum and trans-Golgi network.
Zhou P; Goldstein S; Devadas K; Tewari D; Notkins AL
J Immunol; 1998 Feb; 160(3):1489-96. PubMed ID: 9570571
[TBL] [Abstract][Full Text] [Related]
11. The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli.
Glockshuber R; Schmidt T; Plückthun A
Biochemistry; 1992 Feb; 31(5):1270-9. PubMed ID: 1736986
[TBL] [Abstract][Full Text] [Related]
12. Improving scFv antibody expression levels in the plant cytosol.
Schouten A; Roosien J; de Boer JM; Wilmink A; Rosso MN; Bosch D; Stiekema WJ; Gommers FJ; Bakker J; Schots A
FEBS Lett; 1997 Sep; 415(2):235-41. PubMed ID: 9351003
[TBL] [Abstract][Full Text] [Related]
13. The use of intracellular single-chain antibody fragments to inhibit specifically the expression of cell surface molecules.
Greenman J; Jones E; Wright MD; Barclay AN
J Immunol Methods; 1996 Aug; 194(2):169-80. PubMed ID: 8765170
[TBL] [Abstract][Full Text] [Related]
14. Bacterial and plant-produced scFv proteins have similar antigen-binding properties.
Bruyns AM; De Jaeger G; De Neve M; De Wilde C; Van Montagu M; Depicker A
FEBS Lett; 1996 May; 386(1):5-10. PubMed ID: 8635602
[TBL] [Abstract][Full Text] [Related]
15. Expression of a single-chain Fv antibody fragment specific for the hepatitis B surface antigen in transgenic tobacco plants.
Ramírez N; Ayala M; Lorenzo D; Palenzuela D; Herrera L; Doreste V; Pérez M; Gavilond JV; Oramas P
Transgenic Res; 2002 Feb; 11(1):61-4. PubMed ID: 11874103
[TBL] [Abstract][Full Text] [Related]
16. Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain.
Hayhurst A
Protein Expr Purif; 2000 Feb; 18(1):1-10. PubMed ID: 10648163
[TBL] [Abstract][Full Text] [Related]
17. Diverting a protein from its cellular location by intracellular antibodies. The case of p21Ras.
Lener M; Horn IR; Cardinale A; Messina S; Nielsen UB; Rybak SM; Hoogenboom HR; Cattaneo A; Biocca S
Eur J Biochem; 2000 Feb; 267(4):1196-205. PubMed ID: 10672031
[TBL] [Abstract][Full Text] [Related]
18. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.
Nieba L; Honegger A; Krebber C; Plückthun A
Protein Eng; 1997 Apr; 10(4):435-44. PubMed ID: 9194169
[TBL] [Abstract][Full Text] [Related]
19. Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies.
Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Little M
Mol Immunol; 1994 Oct; 31(14):1047-58. PubMed ID: 7935496
[TBL] [Abstract][Full Text] [Related]
20. IgM secretory tailpiece drives multimerisation of bivalent scFv fragments in eukaryotic cells.
Olafsen T; Rasmussen IB; Norderhaug L; Bruland OS; Sandlie I
Immunotechnology; 1998 Oct; 4(2):141-53. PubMed ID: 9853955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
